Author Archives: Krystina Michelle Jarema
Colleagues, If you attended the Campus-Wide Symposium on May 3rd 2019, you were treated to a preview of Remi’s paper that was just published in Science Magazine today: “Passenger hotspot mutations in cancer driven by APOBEC3A and mesoscale genomic features” … Continue reading
Support the Oncoslayers! This year the Oncoslayers are continuing our efforts as part of the Anti-Cancer Challenge to raise funds for cancer research at UCI. The Oncoslayers are committed to slaying the burden of cancer as the official team of … Continue reading
New immunotherapy technique can specifically target tumor cells, UCI study reports “Lab on a chip” technology can be used to create individualized treatments for cancer Irvine, Calif., Nov. 7, 2018 — A new immunotherapy screening prototype developed by University of … Continue reading
Dear Colleagues, With two new grants recently awarded from the NCI, including from the ‘Biden Cancer Moonshot’ initiative, we are looking to hire a new post-doctoral fellow and/or project scientist (depending on experience) in the area of Immunoncology. We are … Continue reading
Note: A light breakfast will be provided during the talks.Everyone is welcome to attend presentations. Disclosure: This announcement does not determine the order of the speakers presenting on that given day.
UCI News Published an article, “Looking at cancer in a whole new way: UCI moves to the national forefront by taking an interdisciplinary systems biology approach to the devastating disease” on June 6th, 2018. This piece highlights the research of … Continue reading
American Association for Cancer Research – Aflac Inc. awards $100,000 to UCI cancer biologist Claudia Benavente for Pediatric Cancer Research. Full article can be found here: https://news.uci.edu/2018/04/26/american-association-for-cancer-research-aflac-inc-awards-100000-to-uci-cancer-biologist-claudia-benavente/ For more about Dr. Benavente, See her UCI Faculty Profile HERE: https://www.faculty.uci.edu For … Continue reading
Note: A light lunch will be served during the talks. Disclosure: This announcement does not determine the order of the speakers presenting on that given day.
Image 1: Human prostate cancer cells (DU145) with dextran (green) in their lysosomes (red). “PTEN deficiency and AMPK activation promote nutrient scavenging and anabolism in prostate cancer cells” Seong M. Kim, Tricia T. Nguyen, Archna Ravi, Peter Kubiniok, Brendan T. … Continue reading
Exciting news, a former student of Dr. David Fruman’s Lab and former T32 appointee Matt Janes is a first author on a Cell paper that came out January 25th, 2018. He is a staff scientist at Wellspring Biosciences, working on KRAS inhibitors. … Continue reading